Viridian Therapeutics, Inc.\DE Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -1.96M6.48M2.54M3.48M4.00M8.39M4.46M1.05M2.96M1.77M0.31M0.30M
Gross Profit -1.96M3.12M-0.02M0.93M4.00M8.39M4.46M1.05M2.96M1.77M0.31M0.30M
Operating items
Research & Development 0.23M0.35M1.00M13.69M19.62M30.42M34.79M28.30M56.89M100.89M159.76M238.25M
Selling, General & Administrative 1.41M6.86M7.69M6.77M10.91M11.05M11.65M13.27M25.80M35.18M95.00M61.08M
Restructuring Costs 2.04M
Other Operating Expenses 0.25M0.10M5.03M-2.04M69.86M
Operating Expenses 4.51M11.19M13.72M20.46M30.54M41.47M46.44M111.43M82.69M136.08M254.76M299.34M
Operating Income -0.20M-6.87M-11.19M-16.99M-26.53M-33.08M-41.98M-110.38M-79.73M-134.30M-254.45M-299.04M
EBIT -0.20M-6.87M-11.19M-16.99M-26.53M-33.08M-41.98M-110.38M-79.73M-134.30M-254.45M-299.04M
Non-operating items
Interest & Investment Income 0.32M4.92M18.56M32.13M
Non Operating Income 0.14M0.04M0.40M1.25M0.94M0.17M0.32M4.43M16.72M29.09M
Net income details
EBT -2.16M-7.89M-11.33M-17.31M-26.91M-33.96M-42.81M-110.89M-79.41M-129.87M-237.73M-269.95M
Profit After Tax -2.16M-7.89M-11.33M-17.27M-26.51M-32.70M-41.87M-110.72M-79.41M-129.87M-237.73M-269.95M
Income from Continuing Operations -2.16M-7.89M-11.33M-17.31M-26.91M-33.96M-42.81M-110.89M-79.41M-129.87M-237.73M-269.95M
Consolidated Net Income -2.16M-7.89M-11.33M-17.31M-26.91M-33.96M-42.81M-110.89M-79.41M-129.87M-237.73M-269.95M
Income towards Parent Company -2.16M-7.89M-11.33M-17.31M-26.91M-33.96M-42.81M-110.89M-79.41M-129.87M-237.73M-269.95M
Preferred Dividend Payments 0.05M0.01M
Net Income towards Common Stockholders -2.44M-7.89M-11.33M-17.32M-26.52M-32.70M-41.87M-110.72M-79.41M-129.87M-237.73M-269.95M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.02M0.02M0.05M0.05M1.49M2.06M2.12M3.91M21.72M40.25M52.59M79.21M
Shares Outstanding (Diluted Average) 3.56M11.92M32.09M44.76M67.89M
EBITDA -0.20M-6.87M-11.19M-16.99M-26.51M-32.71M-41.87M-110.72M-79.56M-130.11M-237.01M-270.30M
Shares Outstanding 0.25M0.71M0.74M2.06M2.32M4.23M23.92M